Skip to content

Construction and application research of a comprehensive evaluation system for the therapeutic efficacy of primary Sjögren's syndrome dry eye based on multimodal imaging technology

Multimodal imaging assessment of the treatment of dry eye syndrome in primary Sjögren's syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600123411
Enrollment
Unknown
Registered
2026-04-26
Start date
2026-05-01
Completion date
Unknown
Last updated
2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry eye

Interventions

Experimental group :physical therapy
control group:eye drops

Sponsors

Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. The diagnosis of Sjögren's syndrome is confirmed 2. No severe diseases of the heart, liver, kidney, or blood system; 3. The patient has signed the informed consent form. 4. Be over 18 years old.

Exclusion criteria

Exclusion criteria: 1. Previous history of ophthalmic surgery, corneal irregular astigmatism, uveitis, fundus lesions, glaucoma, zonular laxity, etc; 2. Those with severely impaired cognitive function, lacking self-awareness, and unable to participate in follow-up visits or experiments without the accompaniment of family members; 3. Participated in other clinical trials within the past 3 months.

Design outcomes

Primary

MeasureTime frame
Anterior segment OCT;Confocal microscope;

Countries

China

Contacts

Public ContactJing Wu

Department of Ophthalmology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

505432643@qq.com+86 21 5203 9999

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 7, 2026